| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostate | 41 | 2022 | 437 | 4.680 |
Why?
|
| Prostatic Neoplasms | 54 | 2022 | 1577 | 4.050 |
Why?
|
| Stromal Cells | 31 | 2017 | 303 | 3.270 |
Why?
|
| Transforming Growth Factor beta | 17 | 2014 | 475 | 1.990 |
Why?
|
| Receptors, Androgen | 20 | 2022 | 410 | 1.690 |
Why?
|
| Tumor Microenvironment | 12 | 2022 | 688 | 1.290 |
Why?
|
| Proteins | 11 | 2014 | 1063 | 1.130 |
Why?
|
| Prostatic Hyperplasia | 7 | 2011 | 117 | 0.980 |
Why?
|
| Fibroblasts | 9 | 2014 | 879 | 0.930 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2022 | 94 | 0.860 |
Why?
|
| Wound Healing | 5 | 2014 | 480 | 0.740 |
Why?
|
| Transforming Growth Factor beta1 | 9 | 2014 | 134 | 0.720 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2021 | 21 | 0.720 |
Why?
|
| Cell Line, Tumor | 26 | 2022 | 3697 | 0.710 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 58 | 0.710 |
Why?
|
| Androgens | 6 | 2022 | 277 | 0.670 |
Why?
|
| Acinetobacter baumannii | 1 | 2021 | 47 | 0.660 |
Why?
|
| Vaccinium macrocarpon | 1 | 2019 | 2 | 0.650 |
Why?
|
| Pectins | 1 | 2019 | 10 | 0.650 |
Why?
|
| Carcinoma | 4 | 2017 | 300 | 0.640 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2014 | 106 | 0.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2017 | 2064 | 0.630 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2019 | 21 | 0.630 |
Why?
|
| Interleukin-8 | 3 | 2011 | 212 | 0.630 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2017 | 70 | 0.620 |
Why?
|
| Extracellular Matrix | 6 | 2022 | 238 | 0.620 |
Why?
|
| Oligosaccharides | 1 | 2019 | 77 | 0.620 |
Why?
|
| Mice, Nude | 14 | 2018 | 757 | 0.610 |
Why?
|
| Male | 86 | 2022 | 65052 | 0.590 |
Why?
|
| Myofibroblasts | 2 | 2014 | 68 | 0.520 |
Why?
|
| Inflammation | 4 | 2014 | 1526 | 0.520 |
Why?
|
| Animals | 69 | 2025 | 34989 | 0.520 |
Why?
|
| Neoplasm Invasiveness | 8 | 2017 | 663 | 0.490 |
Why?
|
| Mice | 42 | 2021 | 18571 | 0.490 |
Why?
|
| Tumor Cells, Cultured | 15 | 2016 | 1047 | 0.480 |
Why?
|
| Muscle, Smooth | 6 | 2004 | 130 | 0.480 |
Why?
|
| Protein Biosynthesis | 4 | 2004 | 590 | 0.460 |
Why?
|
| Adenocarcinoma | 6 | 2014 | 1018 | 0.460 |
Why?
|
| Tenascin | 4 | 2022 | 32 | 0.450 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 38 | 0.440 |
Why?
|
| Epithelial Cells | 8 | 2018 | 903 | 0.440 |
Why?
|
| Cell Line | 14 | 2020 | 2730 | 0.440 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 109 | 0.430 |
Why?
|
| Neoplasms | 5 | 2014 | 2944 | 0.420 |
Why?
|
| Epithelium | 5 | 2011 | 354 | 0.420 |
Why?
|
| Neovascularization, Pathologic | 6 | 2007 | 257 | 0.400 |
Why?
|
| Chemokines | 3 | 2012 | 130 | 0.400 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1997 | 0.400 |
Why?
|
| Cellular Reprogramming | 1 | 2014 | 130 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 2556 | 0.400 |
Why?
|
| Cell Division | 11 | 2014 | 744 | 0.390 |
Why?
|
| Urinary Bladder Neoplasms | 8 | 2019 | 539 | 0.390 |
Why?
|
| Humans | 79 | 2022 | 132334 | 0.380 |
Why?
|
| Macrophages | 3 | 2014 | 693 | 0.370 |
Why?
|
| Ganglia, Spinal | 5 | 2006 | 69 | 0.370 |
Why?
|
| Transcription Factors | 1 | 2021 | 2494 | 0.360 |
Why?
|
| Disease Progression | 12 | 2019 | 2227 | 0.360 |
Why?
|
| Growth Inhibitors | 3 | 1998 | 37 | 0.360 |
Why?
|
| Neurogenesis | 2 | 2013 | 221 | 0.340 |
Why?
|
| Ganglia | 1 | 2010 | 16 | 0.340 |
Why?
|
| Dihydrotestosterone | 10 | 2004 | 72 | 0.340 |
Why?
|
| Models, Biological | 3 | 2017 | 1458 | 0.330 |
Why?
|
| Serine Endopeptidases | 3 | 2017 | 189 | 0.320 |
Why?
|
| Thrombospondins | 1 | 2009 | 14 | 0.310 |
Why?
|
| Urogenital System | 4 | 1995 | 35 | 0.300 |
Why?
|
| Neurites | 3 | 2006 | 45 | 0.300 |
Why?
|
| Transplantation, Heterologous | 5 | 2009 | 273 | 0.290 |
Why?
|
| Pancreas | 1 | 2009 | 222 | 0.280 |
Why?
|
| Aging | 3 | 2015 | 1261 | 0.280 |
Why?
|
| Immunohistochemistry | 9 | 2016 | 1723 | 0.280 |
Why?
|
| Rats | 19 | 2009 | 3619 | 0.270 |
Why?
|
| Zika Virus | 2 | 2020 | 151 | 0.270 |
Why?
|
| Cell Proliferation | 10 | 2020 | 2512 | 0.270 |
Why?
|
| RNA, Small Interfering | 3 | 2022 | 691 | 0.270 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 53 | 0.270 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2005 | 295 | 0.270 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2008 | 41 | 0.270 |
Why?
|
| Homeostasis | 1 | 2011 | 730 | 0.270 |
Why?
|
| Coculture Techniques | 6 | 2014 | 239 | 0.270 |
Why?
|
| Cell Differentiation | 6 | 2021 | 1975 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 3 | 2009 | 728 | 0.260 |
Why?
|
| Benzamides | 2 | 2018 | 124 | 0.250 |
Why?
|
| Mice, Transgenic | 8 | 2016 | 2453 | 0.250 |
Why?
|
| Immediate-Early Proteins | 2 | 2005 | 59 | 0.240 |
Why?
|
| Prostate-Specific Antigen | 5 | 2022 | 272 | 0.240 |
Why?
|
| Tissue Array Analysis | 4 | 2019 | 140 | 0.240 |
Why?
|
| Receptors, Calcitriol | 2 | 2017 | 61 | 0.240 |
Why?
|
| Liriodendron | 1 | 2025 | 1 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2022 | 1303 | 0.240 |
Why?
|
| Sesquiterpenes | 1 | 2025 | 26 | 0.240 |
Why?
|
| Lactones | 1 | 2025 | 37 | 0.240 |
Why?
|
| Loss of Heterozygosity | 2 | 2008 | 130 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 10 | 2018 | 4767 | 0.230 |
Why?
|
| Cell Communication | 3 | 2009 | 187 | 0.230 |
Why?
|
| Cell Lineage | 2 | 2019 | 359 | 0.230 |
Why?
|
| Disease-Free Survival | 6 | 2016 | 956 | 0.230 |
Why?
|
| Cell Nucleus | 5 | 2004 | 596 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2013 | 634 | 0.220 |
Why?
|
| Myoblasts | 1 | 2004 | 37 | 0.220 |
Why?
|
| Molecular Structure | 2 | 2025 | 319 | 0.220 |
Why?
|
| Receptors, Steroid | 9 | 1988 | 175 | 0.220 |
Why?
|
| Prostatectomy | 5 | 2022 | 356 | 0.200 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 2683 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1998 | 520 | 0.200 |
Why?
|
| 3T3 Cells | 4 | 2018 | 124 | 0.200 |
Why?
|
| Immunoglobulin G | 2 | 1998 | 803 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 1292 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2016 | 1046 | 0.190 |
Why?
|
| Glucuronosyltransferase | 1 | 2022 | 62 | 0.190 |
Why?
|
| Cytoplasm | 3 | 2004 | 270 | 0.190 |
Why?
|
| Interleukin-1alpha | 1 | 2021 | 10 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2014 | 1085 | 0.180 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 587 | 0.180 |
Why?
|
| Mesoderm | 2 | 2011 | 110 | 0.180 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 133 | 0.180 |
Why?
|
| Protein Precursors | 2 | 2002 | 156 | 0.180 |
Why?
|
| Collagen | 2 | 2019 | 309 | 0.180 |
Why?
|
| Semaphorins | 2 | 2013 | 33 | 0.180 |
Why?
|
| Anti-Infective Agents | 2 | 2019 | 271 | 0.180 |
Why?
|
| Parabens | 1 | 2021 | 3 | 0.180 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2021 | 4 | 0.180 |
Why?
|
| Bradyrhizobium | 1 | 2021 | 3 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 422 | 0.180 |
Why?
|
| Drug Antagonism | 1 | 2021 | 12 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 352 | 0.180 |
Why?
|
| Zika Virus Infection | 2 | 2020 | 175 | 0.180 |
Why?
|
| Apoptosis | 6 | 2014 | 1903 | 0.180 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 1541 | 0.180 |
Why?
|
| Bone Neoplasms | 3 | 2018 | 445 | 0.170 |
Why?
|
| Antibodies | 5 | 2006 | 368 | 0.170 |
Why?
|
| Receptors, CXCR3 | 1 | 2020 | 23 | 0.170 |
Why?
|
| Cell Movement | 5 | 2017 | 891 | 0.170 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 302 | 0.170 |
Why?
|
| Chemokine CXCL10 | 1 | 2020 | 53 | 0.170 |
Why?
|
| Granulocytes | 1 | 2020 | 69 | 0.170 |
Why?
|
| Bone and Bones | 2 | 2017 | 301 | 0.170 |
Why?
|
| RNA Helicases | 1 | 2021 | 70 | 0.170 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 1683 | 0.170 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 136 | 0.170 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 49 | 0.160 |
Why?
|
| Mice, Knockout | 5 | 2018 | 3873 | 0.160 |
Why?
|
| Plant Preparations | 1 | 2019 | 15 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2019 | 39 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 150 | 0.160 |
Why?
|
| Nitriles | 2 | 2014 | 155 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 60 | 0.160 |
Why?
|
| Vimentin | 4 | 2009 | 69 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 5 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 149 | 0.160 |
Why?
|
| Discoidin Domain Receptor 1 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Carcinoma, Small Cell | 1 | 2019 | 42 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 190 | 0.150 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 175 | 0.150 |
Why?
|
| Bacterial Adhesion | 1 | 2019 | 106 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 309 | 0.150 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2019 | 41 | 0.150 |
Why?
|
| RNA, Messenger | 5 | 2016 | 2687 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2013 | 1598 | 0.150 |
Why?
|
| Cell Plasticity | 1 | 2019 | 35 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 298 | 0.150 |
Why?
|
| Neoplasm Transplantation | 7 | 2013 | 383 | 0.150 |
Why?
|
| Peripheral Nerves | 3 | 2008 | 88 | 0.150 |
Why?
|
| Genetic Therapy | 5 | 2003 | 720 | 0.150 |
Why?
|
| Monocytes | 1 | 2020 | 345 | 0.150 |
Why?
|
| Connective Tissue | 3 | 1995 | 28 | 0.140 |
Why?
|
| Up-Regulation | 7 | 2016 | 879 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 109 | 0.140 |
Why?
|
| Peptide Fragments | 2 | 2002 | 799 | 0.140 |
Why?
|
| Virus Replication | 2 | 2020 | 636 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 503 | 0.140 |
Why?
|
| Disulfides | 1 | 1998 | 82 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 825 | 0.140 |
Why?
|
| Denervation | 1 | 2017 | 29 | 0.140 |
Why?
|
| Osteogenesis | 1 | 2018 | 163 | 0.140 |
Why?
|
| Cell Adhesion | 2 | 2017 | 327 | 0.140 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2017 | 39 | 0.140 |
Why?
|
| Viral Tropism | 1 | 2018 | 53 | 0.130 |
Why?
|
| B-Lymphocytes | 2 | 1998 | 543 | 0.130 |
Why?
|
| Signal Transduction | 6 | 2020 | 4725 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 292 | 0.130 |
Why?
|
| Integrins | 1 | 2017 | 94 | 0.130 |
Why?
|
| Genetic Vectors | 6 | 2013 | 927 | 0.130 |
Why?
|
| Neoplasm Proteins | 3 | 2014 | 701 | 0.130 |
Why?
|
| Retroviridae | 1 | 2017 | 194 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 998 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2016 | 123 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 544 | 0.120 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 54 | 0.120 |
Why?
|
| Connective Tissue Cells | 2 | 1995 | 5 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2016 | 38 | 0.120 |
Why?
|
| Phenotype | 5 | 2017 | 4545 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 137 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2018 | 330 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2016 | 61 | 0.120 |
Why?
|
| Wnt Proteins | 2 | 2013 | 223 | 0.120 |
Why?
|
| Actins | 3 | 2009 | 338 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2013 | 1570 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 130 | 0.120 |
Why?
|
| Base Sequence | 3 | 2010 | 2904 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2014 | 159 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 929 | 0.120 |
Why?
|
| Organoids | 2 | 2017 | 301 | 0.120 |
Why?
|
| Mice, Inbred C3H | 7 | 2000 | 118 | 0.120 |
Why?
|
| Mitogens | 1 | 1995 | 31 | 0.120 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2017 | 166 | 0.120 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 34 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Microvessels | 1 | 2015 | 66 | 0.110 |
Why?
|
| Pteridines | 1 | 2014 | 12 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 15 | 0.110 |
Why?
|
| Kallikreins | 1 | 2014 | 31 | 0.110 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 4695 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 256 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 816 | 0.110 |
Why?
|
| Osteopontin | 1 | 2014 | 51 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 725 | 0.110 |
Why?
|
| Fibronectins | 1 | 2014 | 107 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 243 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 615 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 62 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 2 | 2008 | 333 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 137 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 237 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 608 | 0.110 |
Why?
|
| Neuroepithelial Cells | 1 | 2013 | 9 | 0.110 |
Why?
|
| Isoantigens | 1 | 1993 | 24 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2008 | 285 | 0.100 |
Why?
|
| Gelatinases | 1 | 2013 | 16 | 0.100 |
Why?
|
| Immunologic Surveillance | 2 | 1990 | 16 | 0.100 |
Why?
|
| Gene Silencing | 3 | 2009 | 240 | 0.100 |
Why?
|
| Receptors, Antigen | 1 | 2013 | 33 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 226 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 263 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1829 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 152 | 0.100 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 591 | 0.100 |
Why?
|
| Murine hepatitis virus | 1 | 2012 | 3 | 0.100 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2011 | 91 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 1993 | 153 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 438 | 0.100 |
Why?
|
| Cell Survival | 3 | 2020 | 869 | 0.100 |
Why?
|
| Physician's Role | 1 | 2014 | 169 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 470 | 0.090 |
Why?
|
| Immunity, Cellular | 2 | 1990 | 204 | 0.090 |
Why?
|
| Transfection | 2 | 2013 | 999 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2013 | 5150 | 0.090 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1880 | 0.090 |
Why?
|
| Adenoviruses, Human | 2 | 2003 | 97 | 0.090 |
Why?
|
| Thymidine Kinase | 5 | 2003 | 90 | 0.090 |
Why?
|
| Tumor Burden | 3 | 2017 | 249 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2011 | 92 | 0.090 |
Why?
|
| Dexamethasone | 1 | 1992 | 273 | 0.080 |
Why?
|
| Time Factors | 5 | 2016 | 6455 | 0.080 |
Why?
|
| Biopsy | 3 | 2017 | 1288 | 0.080 |
Why?
|
| Neutrophils | 1 | 2012 | 359 | 0.080 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 20 | 0.080 |
Why?
|
| Sarcoma, Experimental | 1 | 1990 | 16 | 0.080 |
Why?
|
| Urinary Bladder | 3 | 2019 | 257 | 0.080 |
Why?
|
| Fibrosarcoma | 1 | 1990 | 26 | 0.080 |
Why?
|
| Arthroplasty, Replacement | 1 | 2010 | 26 | 0.080 |
Why?
|
| Cytosol | 6 | 1986 | 144 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 637 | 0.080 |
Why?
|
| Ganciclovir | 4 | 2003 | 101 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2010 | 194 | 0.080 |
Why?
|
| Students, Medical | 1 | 2014 | 362 | 0.080 |
Why?
|
| Orthopedics | 1 | 1990 | 78 | 0.080 |
Why?
|
| Female | 19 | 2019 | 70786 | 0.080 |
Why?
|
| Molecular Weight | 8 | 1995 | 310 | 0.080 |
Why?
|
| Prognosis | 3 | 2022 | 5009 | 0.080 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2003 | 186 | 0.070 |
Why?
|
| Chorioallantoic Membrane | 2 | 2019 | 12 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 329 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2000 | 454 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2007 | 3062 | 0.070 |
Why?
|
| Chick Embryo | 2 | 2019 | 121 | 0.070 |
Why?
|
| Serpins | 1 | 2008 | 34 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 722 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 652 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2000 | 813 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 288 | 0.070 |
Why?
|
| Adenoviridae | 3 | 2000 | 596 | 0.070 |
Why?
|
| Molybdenum | 2 | 1984 | 12 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2013 | 454 | 0.070 |
Why?
|
| Estrenes | 5 | 1986 | 18 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1132 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 123 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2013 | 266 | 0.070 |
Why?
|
| Gene Transfer Techniques | 2 | 2017 | 350 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 1759 | 0.070 |
Why?
|
| Culture Media | 3 | 1995 | 183 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1556 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 241 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 1071 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 1052 | 0.060 |
Why?
|
| Graft Survival | 1 | 2009 | 475 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 1367 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2006 | 50 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2010 | 569 | 0.060 |
Why?
|
| Neurons | 1 | 2016 | 2016 | 0.060 |
Why?
|
| Receptors, Fc | 2 | 1998 | 33 | 0.060 |
Why?
|
| Growth Substances | 2 | 2001 | 109 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 21 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 277 | 0.060 |
Why?
|
| DNA | 4 | 2000 | 1484 | 0.060 |
Why?
|
| Gene Expression | 2 | 2013 | 1564 | 0.060 |
Why?
|
| Testosterone Congeners | 2 | 1984 | 17 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 2673 | 0.060 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1998 | 25 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 234 | 0.060 |
Why?
|
| Tritium | 3 | 1995 | 117 | 0.060 |
Why?
|
| Genistein | 1 | 2004 | 39 | 0.060 |
Why?
|
| Seminal Vesicles | 3 | 2013 | 56 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 503 | 0.050 |
Why?
|
| Sulfones | 1 | 2004 | 73 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2004 | 383 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 3780 | 0.050 |
Why?
|
| Cell Death | 1 | 2004 | 243 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 482 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1998 | 1227 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1995 | 276 | 0.050 |
Why?
|
| Desmin | 1 | 2003 | 20 | 0.050 |
Why?
|
| Recurrence | 2 | 2007 | 1458 | 0.050 |
Why?
|
| Thymidine | 2 | 1995 | 53 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 169 | 0.050 |
Why?
|
| Middle Aged | 6 | 2017 | 28888 | 0.050 |
Why?
|
| CHO Cells | 1 | 2003 | 158 | 0.050 |
Why?
|
| Exons | 2 | 2000 | 803 | 0.050 |
Why?
|
| Rats, Inbred Strains | 6 | 1992 | 222 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 269 | 0.050 |
Why?
|
| Biological Transport | 1 | 2004 | 358 | 0.050 |
Why?
|
| Lung | 3 | 2019 | 1555 | 0.050 |
Why?
|
| Cricetinae | 1 | 2003 | 381 | 0.050 |
Why?
|
| RNA | 1 | 1986 | 549 | 0.050 |
Why?
|
| Aged | 5 | 2016 | 21379 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 142 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 222 | 0.050 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 5 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 7 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 2303 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2003 | 615 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 237 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 2000 | 309 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2006 | 554 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 1992 | 157 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2001 | 92 | 0.040 |
Why?
|
| Swine | 2 | 2004 | 1197 | 0.040 |
Why?
|
| Laminin | 1 | 2001 | 72 | 0.040 |
Why?
|
| Serial Passage | 1 | 2020 | 19 | 0.040 |
Why?
|
| Adult | 4 | 2014 | 31618 | 0.040 |
Why?
|
| Haplorhini | 1 | 2020 | 117 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1451 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 126 | 0.040 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2000 | 31 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2001 | 279 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 2000 | 140 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 369 | 0.040 |
Why?
|
| Culicidae | 1 | 2020 | 75 | 0.040 |
Why?
|
| Young Adult | 1 | 2014 | 9945 | 0.040 |
Why?
|
| Fetus | 2 | 1995 | 599 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2446 | 0.040 |
Why?
|
| Genes | 1 | 2000 | 314 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 412 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 1990 | 81 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 604 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 304 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2000 | 241 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2019 | 40 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 263 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 89 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 617 | 0.040 |
Why?
|
| U937 Cells | 1 | 2018 | 23 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 46 | 0.040 |
Why?
|
| Connexin 43 | 1 | 2018 | 34 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 775 | 0.040 |
Why?
|
| Everolimus | 1 | 2018 | 50 | 0.040 |
Why?
|
| Rabbits | 2 | 1998 | 688 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 1807 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 796 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 217 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 399 | 0.040 |
Why?
|
| Americas | 1 | 2018 | 52 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1998 | 52 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 44 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 414 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1998 | 53 | 0.030 |
Why?
|
| Breast | 1 | 2019 | 216 | 0.030 |
Why?
|
| Lymphokines | 1 | 1998 | 66 | 0.030 |
Why?
|
| Virus Cultivation | 1 | 2018 | 76 | 0.030 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2017 | 19 | 0.030 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2017 | 4 | 0.030 |
Why?
|
| Chemical Phenomena | 4 | 1992 | 83 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1995 | 83 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 1098 | 0.030 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 12 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 100 | 0.030 |
Why?
|
| Second Harmonic Generation Microscopy | 1 | 2016 | 5 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 232 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2018 | 254 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 199 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 1294 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2006 | 124 | 0.030 |
Why?
|
| Ki-67 Antigen | 2 | 2006 | 118 | 0.030 |
Why?
|
| Kinetics | 3 | 1995 | 1178 | 0.030 |
Why?
|
| Chemistry, Physical | 3 | 1992 | 31 | 0.030 |
Why?
|
| Simplexvirus | 3 | 2003 | 100 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2013 | 761 | 0.030 |
Why?
|
| Affinity Labels | 3 | 1984 | 10 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1995 | 56 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 516 | 0.030 |
Why?
|
| Vitamin D | 1 | 2017 | 180 | 0.030 |
Why?
|
| Histology | 1 | 1995 | 1 | 0.030 |
Why?
|
| Finasteride | 1 | 2015 | 18 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 806 | 0.030 |
Why?
|
| MEDLINE | 1 | 1995 | 20 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1995 | 44 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2005 | 425 | 0.030 |
Why?
|
| Species Specificity | 2 | 2013 | 543 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1998 | 444 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 2006 | 137 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 527 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 264 | 0.030 |
Why?
|
| Estradiol | 2 | 1992 | 488 | 0.030 |
Why?
|
| Metribolone | 5 | 1986 | 29 | 0.030 |
Why?
|
| Testosterone | 7 | 1986 | 611 | 0.030 |
Why?
|
| Behavior | 1 | 2014 | 74 | 0.030 |
Why?
|
| Binding, Competitive | 5 | 1984 | 161 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 578 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1126 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 64 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 1083 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1733 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 82 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 1993 | 107 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 187 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2013 | 114 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2017 | 804 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 149 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 1992 | 26 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1992 | 75 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 1230 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 242 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 774 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17363 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 1426 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 348 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 38 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 1990 | 56 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 1125 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2012 | 388 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 1987 | 97 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 180 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1992 | 332 | 0.020 |
Why?
|
| Progesterone | 1 | 1992 | 450 | 0.020 |
Why?
|
| Graft Rejection | 2 | 1992 | 560 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 127 | 0.020 |
Why?
|
| DNA Replication | 1 | 1992 | 353 | 0.020 |
Why?
|
| United Kingdom | 1 | 2010 | 234 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1986 | 57 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 1585 | 0.020 |
Why?
|
| Clone Cells | 1 | 1990 | 179 | 0.020 |
Why?
|
| Chromatography, Affinity | 2 | 1986 | 60 | 0.020 |
Why?
|
| Keratins | 1 | 2009 | 52 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1990 | 202 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 7111 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 459 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2931 | 0.020 |
Why?
|
| Genitalia, Male | 1 | 1988 | 35 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 96 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3628 | 0.020 |
Why?
|
| Organogenesis | 1 | 2008 | 82 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2013 | 748 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 210 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 1368 | 0.020 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2006 | 4 | 0.020 |
Why?
|
| Coronavirus Infections | 1 | 2012 | 379 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 679 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2006 | 13 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2006 | 35 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 234 | 0.020 |
Why?
|
| Cellulose | 1 | 1986 | 27 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 210 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 90 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2006 | 24 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2006 | 45 | 0.020 |
Why?
|
| Nandrolone | 1 | 1986 | 6 | 0.020 |
Why?
|
| Antiviral Agents | 2 | 2003 | 822 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 460 | 0.020 |
Why?
|
| Caspases | 1 | 2006 | 166 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 611 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2006 | 72 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1720 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 143 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 1035 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 1985 | 79 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 246 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1984 | 164 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 296 | 0.010 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2003 | 25 | 0.010 |
Why?
|
| Uterus | 1 | 1987 | 547 | 0.010 |
Why?
|
| Mitomycin | 1 | 2003 | 53 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 111 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 234 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 13192 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 1038 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2003 | 443 | 0.010 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1981 | 67 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2003 | 303 | 0.010 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2003 | 195 | 0.010 |
Why?
|
| Cisplatin | 1 | 2003 | 281 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 804 | 0.010 |
Why?
|
| Binding Sites | 1 | 1984 | 1253 | 0.010 |
Why?
|
| Methotrexate | 1 | 2003 | 351 | 0.010 |
Why?
|
| Herpesviridae | 1 | 2000 | 34 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 3980 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 2000 | 56 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 3022 | 0.010 |
Why?
|
| Adolescent | 1 | 1998 | 20552 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1297 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1669 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2000 | 439 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10910 | 0.010 |
Why?
|
| Child | 1 | 1998 | 25823 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 826 | 0.010 |
Why?
|
| Cattle | 2 | 1987 | 576 | 0.010 |
Why?
|
| Castration | 2 | 1984 | 28 | 0.010 |
Why?
|
| Chimera | 1 | 1992 | 84 | 0.010 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1992 | 101 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 6248 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1990 | 45 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1990 | 45 | 0.010 |
Why?
|
| Curriculum | 1 | 1995 | 765 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 64 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1988 | 190 | 0.000 |
Why?
|
| Orchiectomy | 1 | 1987 | 54 | 0.000 |
Why?
|
| Epididymis | 1 | 1987 | 68 | 0.000 |
Why?
|
| Epitopes | 1 | 1988 | 437 | 0.000 |
Why?
|
| Promegestone | 1 | 1986 | 22 | 0.000 |
Why?
|
| Chemistry | 1 | 1986 | 55 | 0.000 |
Why?
|
| Androgen-Binding Protein | 1 | 1985 | 26 | 0.000 |
Why?
|
| Transferrin | 1 | 1985 | 47 | 0.000 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1985 | 47 | 0.000 |
Why?
|
| Receptors, FSH | 1 | 1985 | 20 | 0.000 |
Why?
|
| Heterochromatin | 1 | 1985 | 48 | 0.000 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1984 | 42 | 0.000 |
Why?
|
| RNA, Ribosomal | 1 | 1985 | 57 | 0.000 |
Why?
|
| Inhibins | 1 | 1985 | 87 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1984 | 58 | 0.000 |
Why?
|
| Indicators and Reagents | 1 | 1984 | 51 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1985 | 193 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1983 | 17 | 0.000 |
Why?
|
| Triamcinolone Acetonide | 1 | 1984 | 34 | 0.000 |
Why?
|
| Protease Inhibitors | 1 | 1984 | 97 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1984 | 364 | 0.000 |
Why?
|
| Receptors, Cell Surface | 1 | 1985 | 452 | 0.000 |
Why?
|
| Receptors, Progesterone | 1 | 1986 | 681 | 0.000 |
Why?
|
| Chickens | 1 | 1981 | 305 | 0.000 |
Why?
|
| Estradiol Congeners | 1 | 1979 | 3 | 0.000 |
Why?
|
| Vacuoles | 1 | 1979 | 29 | 0.000 |
Why?
|
| Mitochondria, Muscle | 1 | 1979 | 39 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1979 | 136 | 0.000 |
Why?
|
| Atrophy | 1 | 1979 | 253 | 0.000 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1979 | 154 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1979 | 246 | 0.000 |
Why?
|